Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
11,662,818
-
Shares change
-
-548,323
-
Total reported value, excl. options
-
$25,306,458
-
Value change
-
-$3,651,260
-
Number of buys
-
40
-
Number of sells
-
20
-
Price
-
$2.17
Institutional Holders of Metagenomi, Inc. - COM (MGX) as of Q3 2024
As of 30 Sep 2024 Metagenomi, Inc. - COM (MGX) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,662,818 shares of stock of the company.
Largest 10 holders included Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, CITADEL ADVISORS LLC, HHLR ADVISORS, LTD., Sozo Ventures GP II, L.P., BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC.
This table shows 65 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.